SRRK — Scholar Rock Holding Share News
0.000.00%
Last trade - 00:00Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. RESEARCH ROUNDUP- Asana, PPG Industries, Verisign
U.S. STOCKS ON THE MOVE -Marvell, Allbirds, Immunic
U.S. STOCKS ON THE MOVE -Shake Shack, Perpetua, Caribou Biosciences
U.S. STOCKS ON THE MOVE-Stryker, TD Synnex, Factset
Scholar Rock up after refiling FDA application for genetic disorder drug
U.S. RESEARCH ROUNDUP-Crowdstrike, Oracle, Vulcan Materials
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy
U.S. STOCKS ON THE MOVE-Pinterest, Best Buy, Dave
Scholar Rock rises after plan to resubmit application for muscle disorder drug
Brief: Scholar Rock FY Income From Operations USD -384.645 Million
Scholar Rock Q4 net loss widens; secures new debt facility
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Scholar Rock falls on FDA review; analysts flag optimistic expectations
Structure Therapeutics doubles while other obesity drug developers decline
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up